These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 363945)

  • 1. Antigen-induced murine B cell lymphomas. I. Induction and characterization of CH1 and CH2.
    Lynes MA; Lanier LL; Babcock GF; Wettstein PJ; Haughton G
    J Immunol; 1978 Dec; 121(6):2352-7. PubMed ID: 363945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity.
    Arnold LW; LoCascio NJ; Lutz PM; Pennell CA; Klapper D; Haughton G
    J Immunol; 1983 Oct; 131(4):2064-8. PubMed ID: 6194226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-induced murine B cell lymphomas. II. Exploitation of the surface idiotype as tumor specific antigen.
    Haughton G; Lanier LL; Babcock GF; Lynes MA
    J Immunol; 1978 Dec; 121(6):2358-62. PubMed ID: 82581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a spontaneous murine B cell leukemia (BCL1). I. Cell surface expression of IgM, IgD, Ia, and FcR.
    Knapp MR; Jones PP; Black SJ; Vitetta ES; Slavin S; Strober S
    J Immunol; 1979 Sep; 123(3):992-9. PubMed ID: 313960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor mediated leukemogenesis: murine leukemia virus interacts with BCL1 lymphoma cell surface IgM.
    McGrath MS; Tamura G; Weissman IL
    J Mol Cell Immunol; 1987; 3(4):227-42. PubMed ID: 2855408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and characterization of membrane immunoglobulin, Ia, and H-2 molecules of thy 1+ AKR/J lymphomas.
    Schwartz BD; Campbell PS; Asofsky R; Greenberg RS; Zatz MM
    J Immunol; 1977 Nov; 119(5):1706-10. PubMed ID: 410882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced differentiation of a B cell lymphoma with known antigen specificity.
    LoCascio NJ; Arnold LW; Corley RB; Haughton G
    J Mol Cell Immunol; 1984; 1(3):177-90. PubMed ID: 6242857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, distribution and specificity of Fc receptors for IgM on murine B cells.
    Mathur A; Lynch RG; Köhler G
    J Immunol; 1988 Sep; 141(6):1855-62. PubMed ID: 2971716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1.
    Tamura GS; McGrath MS; Weissman IL
    J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane immunoglobulins of spontaneous B lymphomas of aged BALB/c mice.
    Laskov R; Kim JK; Woods VL; McKeever PE; Asofsky R
    Eur J Immunol; 1981 Jun; 11(6):462-8. PubMed ID: 6790290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface antigens expressed by subsets of pre-B cells and B cells.
    McKearn JP; Baum C; Davie JM
    J Immunol; 1984 Jan; 132(1):332-9. PubMed ID: 6606670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturally occurring leukemia viruses in H-2 congenic C57BL mice. I. High lymphoma incidence following milk-borne transmission of virus.
    Melief CJ; Vlug A; de Goede RE; de Bruyne C; Barendsen W; de Greeve P
    J Natl Cancer Inst; 1980 May; 64(5):1179-89. PubMed ID: 6245301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
    Ciavarra RP; Vitetta ES; Forman J
    J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific lymphocyte-target cell conjugate formation between tumor-specific helper T-cell hybridomas and IA-bearing RCS tumors and IE-bearing allogeneic cells. I. Role of Ia and both L3T4 and LFA-1 antigens in recognition/binding.
    Ohnishi K; Bonavida B
    J Immunol; 1986 Dec; 137(11):3681-8. PubMed ID: 2946766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine IgA binding factors (IgA-BF) suppressing IgA production: characterization and target specificity of IgA-BF.
    Noro N; Adachi M; Yasuda K; Masuda T; Yodoi J
    J Immunol; 1986 Apr; 136(8):2910-6. PubMed ID: 3514749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
    Mackel AM; Craddock GR; Warr GW; DeLuca D; Marchalonis JJ
    J Immunol; 1983 Sep; 131(3):1582-90. PubMed ID: 6350458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative immunofluorescent analysis of surface phenotypes of murine B cell lymphomas and plasmacytomas with monoclonal antibodies.
    Lanier LL; Warner NL; Ledbetter JA; Herzenberg LA
    J Immunol; 1981 Oct; 127(4):1691-7. PubMed ID: 7024413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.